Many biopharma companies rely on firmographic segmentation—categorizing prospects by company size, industry, or development stage—to guide their marketing and sales efforts. However, these surface-level characteristics rarely explain how organizations make decisions or what outcomes they are trying to achieve. By incorporating behavioral, psychographic, and outcomes-based segmentation, companies can better identify the customers most likely to benefit from their solutions, tailor messaging to stakeholder priorities, and improve commercial performance. Effective segmentation goes beyond who a company is—it reveals why they buy, how they decide, and what success looks like for them.

I’m thrilled to share my updated executive biography, detailing my journey and experiences in the BioPharma sector. With over 26 years of experience in Marketing, Sales, and Operations, I’ve had the privilege of leading innovative projects and driving significant growth at companies like Evofem Biosciences. In my role, I focus on crafting and executing strategic initiatives that enhance patient care and advance healthcare solutions. My commitment to integrity, strategic excellence, and effective communication has guided me in achieving impactful results and fostering empowered teams.